Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study (Q28660706)
Jump to navigation
Jump to search
scientific article (publication date: 2014)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study |
scientific article (publication date: 2014) |
Statements
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study (English)
0 references
January 2014
0 references
73
0 references
1
0 references
183-90
0 references
1 reference
1 reference
1 reference
1 reference